ATOSSA THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.1M | $-6.4M | $-15.8M | $-14.7M | $-10.8M | $-5.1M | $-3.4M | $-1.1M |
| Depreciation & Amortization | $129.0K | $303.5K | $272.6K | $480.3K | $472.9K | $130.6K | $15.6K | — |
| Depreciation | $26.0K | $125.7K | $73.1K | $144.9K | $83.0K | $25.1K | $3.9K | — |
| Amortization | $103.0K | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $840.1K | $556.3K | $1.4M | $121.8K | $140.1K | — |
| Net Cash from Operating Activities | $-6.6M | $-5.4M | $-14.0M | $-10.6M | $-8.8M | $-3.9M | $-3.5M | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-9.2K | $-288.4K | $-343.3K | — | $-134.6K | $-136.9K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.8M | $4.7M | — | — | — | $3.8M | $5.5M | — |
| Net Change in Cash | $4.2M | $-687.9K | $-4.8M | $2.2M | $4.6M | $-185.6K | $1.9M | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |